Gary Hattersley
Nuvotronics (United States)(US)
Publications by Year
Research Areas
Bone health and treatments, Bone health and osteoporosis research, Estrogen and related hormone effects, Bone Metabolism and Diseases, Advanced Breast Cancer Therapies
Most-Cited Works
- → Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis(2016)828 cited
- → Ectopic induction of tendon and ligament in rats by growth and differentiation factors 5, 6, and 7, members of the TGF-beta gene family.(1997)532 cited
- → Binding Selectivity of Abaloparatide for PTH-Type-1-Receptor Conformations and Effects on Downstream Signaling(2015)294 cited
- → Effects of Abaloparatide, a Human Parathyroid Hormone-Related Peptide Analog, on Bone Mineral Density in Postmenopausal Women with Osteoporosis(2014)256 cited
- → The localized expression of extracellular matrix components in healing tendon insertion sites: an in situ hybridization study(2002)253 cited
- → ACTIVExtend: 24 Months of Alendronate After 18 Months of Abaloparatide or Placebo for Postmenopausal Osteoporosis(2018)197 cited
- → A Novel BMP Expressed in Developing Mouse Limb, Spinal Cord, and Tail Bud Is a Potent Mesoderm Inducer inXenopusEmbryos(1999)167 cited
- → RAD1901(2015)158 cited
- → Elacestrant (RAD1901), a Selective Estrogen Receptor Degrader (SERD), Has Antitumor Activity in Multiple ER+ Breast Cancer Patient-derived Xenograft Models(2017)155 cited
- → Cloning and Expression of the Wnt Antagonists Sfrp-2 and Frzb during Chick Development(2000)155 cited